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Abstract
We study the growth rate of a cell population that follows an age-structured PDE with
time-periodic coefficients. Our motivation comes from the comparison between experimental
tumor growth curves in mice endowed with intact or disrupted circadian clocks, known to exert
their influence on the cell division cycle. We compare the growth rate of the model controlled
by a time-periodic control on its coefficients with the growth rate of stationary models of the
same nature, but with averaged coefficients. We firstly derive a delay differential equation
which allows us to prove several inequalities and equalities on the growth rates. We also
discuss about the necessity to take into account the structure of the cell division cycle for
chronotherapy modeling. Numerical simulations illustrate the results.
Key words: cell cycle, circadian rhythms, chronotherapy, structured PDEs, delay differ-
ential equations.
AMS subject classification: 35F05, 35P05, 35P15, 92B05, 92D25.
1 Cell cycle control and circadian rhythms
The cell division cycle is the process by which the eukaryotic cell duplicates its DNA content
and then divides itself in two daughter cells. This process is normally controlled by various
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physiological mechanisms that ensure homeostasis of healthy tissues, that control genome
integrity (e.g. cyclins and cdks, p53, repair enzymes, etc.), launching programmed cell death
(apoptosis) if the DNA is irreversibly damaged (see [21] for a complete presentation). The
system of control has been extensively studied and modeled (see e.g. [14, 16, 23] or [26])
using ordinary differential equations. The cell division can be modeled through branching
processes (see [2]), integral equations, delay differential equations (see [4]) and also many
structured PDE models (for an overview, see [1, 3, 19]) where the structuring variables can be
age ([22]), size ([24]) or more recently cyclin content ([5, 6, 11]).
Most living organisms exhibit circadian rhythms (from Latin circa diem, “roughly a day”)
which allow them to adapt to an environment that varies with a periodicity of 24h. These
rhythms can be observed even in the smallest biological functional unit, the cell. The problem
we are studying is the growth of cell populations (undergoing the cell division cycle described
above) under the pressure of circadian rhythms. Circadian rhythm effects on the cell cycle turn
out to be important in tumor proliferation. This is observed by several experiments involving
a major disruption of circadian rhythms in mice. In these experiments it can be seen that the
growth of tumors is significantly enhanced in mice in which the pacemaker circadian clock
has been drastically perturbed, either through neurosurgery, or through light-dark cycle dis-
ruption (see e.g. [13, 12]). Moreover, in the clinic, taking advantage of the influence exerted
by circadian clocks on anticancer drug metabolism and on the cell division cycle has led in the
past 15 years to successful applications in the chronotherapy of cancers, particularly colorectal
cancer (see [18]). This motivates modeling the circadian rhythm in simple cell cycle models
and studying these effects on the growth rate of a cell population.
Figure 1: Effects of the perturbation of light-dark cycle on tumor proliferation (reproduced from
[12]). In clock-perturbed mice (black dots), the tumor proliferates much faster than in control mice
(white dots).(By courtesy of Elizabeth Filipski).
Contrary to our first idea, the growth rate of a cell population described by a physiologically
structured PDE model with time-periodic control is not necessarily lower than in a model of
the same nature, but with a time-averaged control [7, 8, 9].
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The goal here is twofold. Firstly we analyze how modeling assumptions lead to define
various growth rates under the effects of circadian rhythms. Secondly we model the effect of
chronotherapy on these growth rates.
In the second section we recall the definition of these various growth rates, in terms of
Perron and Floquet eigenvalues of a linear Von Foerster- Mc-Kendrick model. We also discuss
known inequalities between them. In the third section we study a simple division model,
for which we establish (in Theorem 2) strict inequalities comparing the growth rate in the
stationary (Perron) and periodic (Floquet) cases. These inequalities are proved by studying a
related time delay system (which is similar to the one considered in [4]). This model is used
to confirm the impossibility to derive a general comparison between the Perron and Floquet
eigenvalues defined in the second section. In the fourth section, we give an argument for using
multiphase models to represent chronotherapy, taking better into account the structure of the
cell cycle and particularly the existence of various phases. We provide numerical simulations
to illustrate our results. In a first appendix, we give the detailed proof of the existence of the
solution of the eigenproblem, by applying the Krein-Rutman theorem. In a second appendix,
we derive analytical formulæ for the eigenelements in a specific multiphase case, which yield
further information on their behavior and can be used to validate numerical experiments.
2 The model
2.1 The renewal equation
We base our study on a cell population that follows the classical renewal equation structured
in age with periodic coefficients representing the effect of circadian rhythms{ ∂
∂tn(t, x) +
∂
∂xn(t, x) + d(t, x)n(t, x) = 0,
n(t, x = 0) =
∫∞
0 B(t, x)n(t, x)dx.
(1)
Here n(t, x) represents the density of cells of age x in the cycle at time t, d(t, x), B(t, x)
represent respectively the death rate, and the birth rate. Both these coefficients are T -periodic
in time. We define the growth rate of the population in terms of an eigenproblem. The growth
rate λF (F for Floquet as for ODEs with periodic coefficients) is defined as the unique real
number λF , such that there is a solution N to the problem

∂
∂tN(t, x) +
∂
∂xN(t, x) + [λF + d(t, x)]N(t, x) = 0,
N(t, x = 0) =
∫∞
0 B(t, x)N(t, x)dx,
N > 0, T − periodic.
(2)
We refer to [20] for conditions of existence for λF (and to the appendix for the case of division
models).
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2.2 Comparison of eigenvalues
We use the following notations. For a T -periodic function f we define,
〈f〉 =
1
T
∫ T
0
f(t)dt the arithmetical average,
〈f〉g = exp
( 1
T
∫ T
0
log f(t)dt
)
the geometrical average, when f > 0.
It may seem natural to introduce the following stationary problem (Perron eigenproblem),
in which the death and birth rates are averaged

d
dxNP (x) + [λP + 〈d(x)〉]NP (x) = 0,
NP (0) =
∫∞
0 〈B(x)〉NP (x)dx = 1,
NP (x) > 0.
(3)
It is shown in [8, 9] that, when B does not depend on time, the inequality λF ≥ λP holds.
In the present paper, we show that this inequality does not carry over to the case of a time
dependent B. It should be noted, however, that there is a general inequality, established in
[7], which relates λF with the solution of the following eigenproblem in which an arithmetical
average of the death rate is taken, whereas the geometrical average of the birth rate is taken,

d
dxNg(x) + [λg + 〈d(x)〉]Ng(x) = 0,
Ng(0) =
∫∞
0 〈B(x)〉gNg(x)dx = 1,
Ng(x) > 0.
(4)
Theorem 1 ([7]). The eigenvalues defined in (2) and (4) satisfy
λF ≥ λg.
This result suggests that there is no general inequality between λP and λF , because the
inequality which follows from convexity is λF ≥ λg. Moreover, it follows from the standard
arithmetico-geometrical inequality,
λP ≥ λg.
Such a general comparison cannot hold between λF and λP , as shown in the next section. To
go further we use a more specific model.
3 A simple one-phase division model
3.1 Model and main results
We model the cell cycle with the following PDE which is a particular case of (1),{ ∂
∂tn(t, x) +
∂
∂xn(t, x) + [d(t) +K0ψ(t)χ[a,+∞[(x)]n(t, x) = 0,
n(t, 0) = 2K0ψ(t)
∫∞
a n(t, x)dx,
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where K0 > 0 is a constant, ψ > 0 is a T -periodic function with
〈ψ〉 = 1. (1)
The termK0ψ(t)χ[a,+∞[ represents the division rate, d(t) is the apoptosis rate (we assume it to
be T -periodic). We have denoted by χE the indicator function of setE. Finally, ψ(t) represents
a nonnegative periodic control exerted on division. As before we look for the growth rate λF
of such a system. It is defined so that there is a solution to the Floquet eigenproblem,

∂
∂tN(t, x) +
∂
∂xN(t, x) +
[
λF + d(t) +K0ψ(t)χ[a,+∞[(x)
]
N(t, x) = 0,
N(t, 0) = 2K0ψ(t)
∫∞
a N(t, x)dx,
N > 0, T -periodic,
(2)
and we normalize N by ∫ T
0
∫ ∞
0
N(t, x)dxdt = 1.
As we already know a general comparison result for the geometrical eigenvalue λg defined
in (4), we are now only interested in the comparison of λF and λP , the latter quantity defined
by requiring the existence of a solution to the Perron eigenproblem already defined in (3) which
here reads 

d
dxNP (x) + [λP + 〈d〉 +K0χ[a,+∞[(x)]NP (x) = 0,
NP (0) = 2K0
∫∞
a NP (x)dx,
NP > 0,
(3)
and we normalize NP by
NP (0) = 2K0
∫ ∞
a
NP (x)dx = 1.
We are interested in evaluating the effect of the periodic control ψ(t) on the growth of the
system. Therefore we denote by λF (a, ψ) and by λP (a) the above defined eigenelements so
as to keep track of the problem parameters.
The following theorem implies that there is no possible general comparison between λF
and λP .
Theorem 2. For all continuous positive T -periodic functions ψ satisfying (1), we have
λF (a = T, ψ) = λP (T ) = λF (a = T, 1), (4)
and for a in a neighborhood of T, we have, provided ψ 6≡ 1
λF (a, ψ) > λP (a) = λF (a, 1) for a < T,
λF (a, ψ) < λP (a) = λF (a, 1) for a > T.
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The proof of this theorem is presented in the next sections. The computations done in
section 4.1 insure that, without loss of generality, we can suppose d ≡ 0.
Numerical results are presented in figures 2 and 3 which illustrate this theorem. Graphi-
cally, for fixed ψ, this predicts firstly that the curves of λF (a, ψ) (Floquet curve) and λP (a)
(Perron curve) must cross each other for a = T , secondly that the Floquet curve should be
above the Perron curve before (i.e., for a < T ) the crossing and below this curve after it (i.e.,
for a > T ). A possible interpretation is that for a better adaptation (in the sense of higher
proliferation), the cell cycle should be shorter than 24h; an effect already observed in [4].
3.2 Proof of Theorem 2, part 1 (a delay differential equation)
Throughout the proof, we use the shorter notations λF and λP instead of λF (a, ψ) and λP (a)
when there is no possible confusion.
To find more information on λF we derive a delay differential equation.
We integrate (2) with respect to age over [a,∞[. We get
d
dt
∫ ∞
a
N(t, x)dx+N(t,∞)−N(t, a) + [λF +K0ψ(t)]
∫ ∞
a
N(t, x)dx = 0.
From the formula of characteristics and the boundary condition in (2),
N(t, a) = N(t− a, 0)e−λF a,
N(t, a) = 2K0e
−λF aψ(t− a)
∫∞
a N(t− a, x)dx.
We set P (t) =
∫∞
a N(t, x)dx. Since we have N(t,∞) = 0 (see the appendix) we obtain
the delay differential equation
P˙ (t) +
(
λF +K0ψ(t)
)
P (t) = 2K0ψ(t− a)P (t− a)e
−λF a. (5)
3.3 Proof of Theorem 2, part 2 (equality of growth rates for a = T )
The comparison between λP and λF is based on the following formula for λP .
Lemma 3. The Perron eigenvalue defined in (3) satisfies
∀a > 0,
λP +K0
2K0
eλP a = 1. (6)
Proof. From (3), we have, for x ≥ a, NP (x) = e−(λP+K0)x+K0a. We insert that in the
boundary condition and obtain
1 = 2K0
∫ ∞
a
e−(λP+K0)x+K0adx,
1 = 2K0
1
λP +K0
e−λP a.
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Corollary 4. The Perron eigenvalue defined in (3) satisfies
∀a > 0, λP > 0.
Proof. This follows from Lemma 3 and the remark
∀a > 0,∀λ ≤ 0,
λ+K0
2K0
eλa ≤
1
2
.
To obtain (4), we divide (5) by P and find
P˙ (t)
P (t)
= −λF −K0ψ(t) + 2K0ψ(t− a)
P (t− a)
P (t)
e−λF a.
When we take the average over a period, we get (since P is T -periodic in time by its definition
as N is)
0 = −(λF +K0) + 2K0e
−λF a
〈
ψ(t− a)
P (t− a)
P (t)
〉
,
λF +K0
2K0
eλF a =
〈
ψ(t− a)
P (t− a)
P (t)
〉
. (7)
Now we consider the particular case a = T . As P is T -periodic P (t− a) = P (t). Hence, for
a = T , we arrive at
λF +K0
2K0
eλF a =
〈
ψ(t− a)
P (t− a)
P (t)
〉
= 〈ψ〉 = 1. (8)
This equality is the same for λF as the one described in lemma 1 for λP . As we know that the
mapping
λ 7→
λ+K0
2K0
eλa.
is increasing on [−K0,+∞[ from 0 to +∞ and is negative elsewhere, there is only one solution
to (8) which is also given by (6) and the result (4) is proved.
3.4 Proof of Theorem 2, part 3 (local comparison around a = T )
We fix ψ 6≡ 1. We study the variations of λF+K02K0 e
λF a around a = T . From (7), we know:
λF +K0
2K0
eλF a =
〈
ψ(t− a)
P (t− a)
P (t)
〉
=
〈
ψ(t)
P (t)
P (t+ a)
〉
,
therefore
∂
∂a
λF +K0
2K0
eλF a =
∂
∂a
〈
ψ(t)
P (t)
P (t + a)
〉
,
=
〈
ψ(t)
∂P
∂a
(t)
1
P (t+ a)
〉
+
〈
ψ(t)
−P (t)
P 2(t+ a)
∂
∂a
(
P (t+ a)
)〉
.
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Recalling that P depends on a (as N and λF do), we have
∂
∂a
P (t+ a) =
∂P
∂a
(t+ a) + P˙ (t+ a).
We then split the computations
∂
∂a
λF +K0
2K0
eλF a =
〈
ψ(t)
∂P
∂a
(t)
1
P (t+ a)
〉
−
〈
ψ(t)
P (t)
P 2(t+ a)
(
∂P
∂a
(t+ a) + P˙ (t+ a)
)〉
,
=
〈
ψ(t)
1
P (t + a)
(
∂P
∂a
(t)−
P (t)
P (t+ a)
∂P
∂a
(t+ a)
)〉
−
〈
ψ(t)
P (t)
P 2(t+ a)
P˙ (t+ a)
〉
.
For a = T , the first term vanishes, and P (t+ a) = P (t) i.e.,
∂
∂a
λF +K0
2K0
eλF a = −
〈
ψ(t)
P (t)
P 2(t)
P˙ (t)
〉
= −
〈
ψ(t)
P˙ (t)
P (t)
〉
.
To compute this we again make use of the ODE (5) which we multiply by ψ
P
ψ(t)
P˙ (t)
P (t)
= −λFψ(t) −K0ψ
2(t) + 2K0ψ(t− a)ψ(t)
P (t− a)
P (t)
e−λF a.
Averaging on a period we still get, for a = T ,〈
ψ(t)
P˙ (t)
P (t)
〉
= −λF −K0〈ψ
2〉+ 2K0〈ψ
2〉e−λF a.
Using (8), we arrive at〈
ψ(t)
P˙ (t)
P (t)
〉
= −λF −K0〈ψ
2〉+ 〈ψ2〉(λF +K0) = λF (〈ψ
2〉 − 1).
We now have the derivative at a = T ,
∂
∂a |a=T
λF +K0
2K0
eλF a = −λF (〈ψ
2〉 − 1). (9)
We use here the notations λ′F (T ) for
∂λF
∂a |a=T
and λF (T ) = λP (T ) to recall that we are
studying the local behavior of λF and λP around a = T , (ψ is fixed). We can directly compute
∂
∂a |a=T
λF +K0
2K0
eλF a = λ′F (T )
eλF (T )T
2K0
+ (λ′F (T )T + λF (T ))
K0 + λF (T )
2K0
eλF (T )T ,
Therefore, using (4) and (6), we obtain
∂
∂a |a=T
λF +K0
2K0
eλF a = λ′F (T )
(
eλP (T )T
2K0
+ T
)
+ λF (T ),
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so that, using (4) and (9), we have
λ′F (T ) =
−λP (T )〈ψ
2〉
T + e
λP (T )T
2K0
.
Similarly we have
λ′P (T ) =
−λP (T )
T + e
λP (T )T
2K0
.
Therefore,
λ′P (T )− λ
′
F (T ) =
λP (T )(〈ψ
2〉 − 1)
T + e
λP (T )T
2K0
.
Thanks to corollary 4, λP (T ) is positive. The assumption (1) leads to
〈ψ2〉 − 1 =
〈
(ψ − 1)2
〉
> 0.
Finally we obtain
λ′P (T )− λ
′
F (T ) > 0, (10)
and the second statement of the theorem follows then immediately from (4) and (10).
4 Modeling chronotherapy
In the following we propose a model for chronotherapy by the introduction of a periodic death
rate due to the effect of a drug on our cell division cycle model.
4.1 Limit of single-phase division models
We consider a population of cells following a general division equation with apoptosis rate d.
As above, all coefficients are T -periodic with respect to time.{ ∂
∂tn(t, x) +
∂
∂xn(t, x) +
(
d(t, x) +K(t, x)
)
n(t, x) = 0,
n(t, 0) = 2
∫∞
0 K(t, x)n(t, x)dx.
We consider the Floquet eigenproblem associated with this equation

∂
∂tN(t, x) +
∂
∂xN(t, x) +
(
d(t, x) +K(t, x) + λF
)
N(t, x) = 0,
N(t, 0) = 2
∫∞
0 K(t, x)N(t, x)dx,
N > 0,
∫ T
0
∫∞
0 N(t, x)dxdt = 1
We propose to model the effect of chronotherapy by adding a time T -periodic, age-independent
death rate γ(t) representing the effect of a drug (for instance we may consider γ proportional
to the quantity of drug in the body). The cell population now follows the equation{ ∂
∂tn(t, x) +
∂
∂xn(t, x) + [d(t, x) +K(t, x) + γ(t)]n(t, x) = 0,
n(t, 0) = 2
∫∞
0 K(t, x)n(t, x)dx.
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The Floquet eigenproblem for this equation reads

∂
∂tN
γ(t, x) + ∂∂xN
γ(t, x) +
(
d(t, x) +K(t, x) + γ(t) + λγF
)
Nγ(t, x) = 0,
Nγ(t, 0) = 2
∫∞
0 K(t, x)N
γ(t, x)dx,
Nγ > 0, T − periodic
∫ T
0
∫∞
0 N
γ(t, x)dxdt = 1.
Lemma 5. The Floquet eigenvalue λγF defined above satisfies
λγF = λF − 〈γ〉.
Proof. We define γ˜ = γ−〈γ〉, Γ(t) =
∫ t
0 γ˜(s)ds. Noticing that Γ is T -periodic, we define the
function M by M(t, x) = N(t, x)eΓ˜(t). It satisfies

∂
∂tM(t, x) +
∂
∂xM(t, x) +
(
d(t, x) +K(t, x) + γ(t) + λF − 〈γ〉
)
M(t, x) = 0,
M(t, 0) = 2
∫∞
0 K(t, x)M(t, x)dx,
M > 0, T − periodic.
Therefore λγF = λF − 〈γ〉 and up to a renormalization M = Nγ .
This result expresses that with such a simple model, chronotherapy is inefficient, since
changing the moment of administration of a drug (in symbols, changing γ(t) into γ(t + θ)
where θ is a real number) has no effect on the growth rate. In other words, in such one-phase
models, this effects depends on 〈γ〉. Only the total daily dose of the drug is relevant!
4.2 Using multiphase models
We now consider more realistic multiphase models. We use the additional ingredient that the
real cell division cycle is multiphasic because of the existence of checkpoints between phases
(mainly at the G1/S and G2/M transitions) at which it can be arrested if genome integrity is not
preserved. We consider a cell cycle model with I phases where I > 1 (for instance I = 4 if we
want to represent the classical phases G1-S-G2-M). We study I populations of cells, ni(t, x)
being the density of cells of age x in phase i at time t. We use the convention I + 1 = 1

∂
∂tni(t, x) +
∂
∂xni(t, x) + [Ki→i+1(t, x) + di(t, x)]ni(t, x) = 0,
ni+1(t, 0) =
∫∞
0 Ki→i+1(t, y)ni(t, y)dy, 1 < i
n1(t, 0) = 2
∫∞
0 KI→1(t, y)nI(t, y)dy,
ni(0, x) = n
0
i (x) given.
(1)
Here Ki→i+1 represents the transition rate from phase i to i+1. At the end of phase I division
occurs with rateKI→1. To be as general as possible, we have considered death rates di in phase
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i. As above, the coefficients are time T -periodic and we can consider the Floquet eigenproblem

∂
∂tNi(t, x) +
∂
∂xNi(t, x) + [Ki→i+1(t, x) + di(t, x) + λ]Ni(t, x) = 0,
Ni+1(t, 0) =
∫∞
0 Ki→i+1(t, y)Ni(t, y)dy, 1 < i
N1(t, 0) = 2
∫∞
0 KI→1(t, y)NI(t, y)dy,
Ni > 0, T − periodic,
∑
i
∫ 1
0
∫∞
0 Nidxdt = 1.
(2)
We also consider the adjoint eigenproblem

∂
∂tφi(t, x) +
∂
∂xφi(t, x)− [Ki→i+1(t, x) + di(t, x) + λ]φi(t, x) = Ki→i+1φi+1(t, 0),
∂
∂tφI(t, x) +
∂
∂xφI(t, x) − [KI→1(t, x) + dI(t, x) + λ]φI(t, x) = 2KI→1φ1(t, 0),
φi > 0, T − periodic,
∑
i
∫∞
0 Niφidxdt = 1.
(3)
To model the effect of chronotherapy, we consider a cytotoxic drug acting only on a specific
phase (for instance 5-Fluorouracil acts on S-phase, see [17] for instance and the references
therein) and, as in the previous section we represent its action by an additional death rate in
phase j, γ(t) (we replace in phase j dj by dj + γ) . We also define eigenelements for the
modified equation (λγ , Nγ , φγ). We multiply the first line of (2) (version with dj replaced by
dj + γ, Ni by Nγi and λ by λγ) by φi, and (3) by Nγi . Summing over i and integrating over
age and time, we obtain
(λ− λγ)
∑
i
∫ 1
0
∫ ∞
0
Nγi φidxdt =
∫ 1
0
γ(t)
∫ ∞
0
Nγj φjdxdt. (4)
We shall not have here the problem encountered with one-phase models. We study the effect
of a death rate γ(t + θ). We denote λε,θ, N ε,θ the eigenelements associated to an additional
death rate εγ(t+ θ) in phase j. We define F (ε, θ) by
F (ε, θ) = λ− λε,θ =
∫ 1
0 εγ(t+ θ)
∫∞
0 N
ε,θ
j φjdxdt∑
i
∫ 1
0
∫∞
0 N
ε,θ
i φidxdt
. (5)
As we have λ = λ0,θ for any θ, F (0, θ) ≡ 0. Particularly it does not depend on θ. The question
is: does F (ε, θ) depend on θ for fixed ε? To assess this question, we compute using dominated
convergence
∂λ(ε, θ)
∂ε
|ε=0= lim
ε→0
F (ε, θ)
ε
=
∫ 1
0
γ(t+ θ)
∫ ∞
0
Njφjdxdt. (6)
Therefore if neither the function γ(.) nor the function
∫∞
0 Njφj(., x)dx are constant (contrarily
to one-phase models, there are no compensating effect making
∫∞
0 Njφj(., x)dx constant, see
for instance the computations of the appendix), then lim
ε→0
F (ε, θ)
ε
depends on θ (we mean it
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is not a constant function of θ) and so is (at least for small ε) F (ε, .). In this case the Taylor
first order approximation around 0 of λ: λ(ε, θ) ≈ λ + ε
∫ 1
0 γ(t + θ)
∫∞
0 Njφjdxdt is not
a constant function of θ and neither is λ(ε, θ), at least for small values of ε. We illustrate
this property numerically in the next section (see figure 5). It seems that the Taylor first order
approximation is a very good approximation of the growth rate for a reasonable range of values
of the amplitude ε.
5 Numerical simulations
We illustrate the theorems proved above by several numerical simulations. We firstly present
the numerical scheme, then we give several algorithmic properties. Finally tests are presented.
5.1 Discretization
In our numerical simulations we consider a pure division model :{ ∂
∂tn(t, x) +
∂
∂xn(t, x) +K0ψ(t)χ[a,+∞[(x)n(t, x) = 0,
n(t, 0) = 2K0ψ(t)
∫∞
a n(t, x)dx.
(1)
Consider time and age increments ∆t,∆x and denote by κi and ψk, the quantities κi =
K0χ[a,+∞[(i∆x) and ψk = ψ(k∆t). Choosing first order finite differences, we obtain from
equation (1) the following approximation with an error of order O(|∆t|+ |∆x|)
nk+1i − n
k
i
∆t
+
nki − n
k
i−1
∆x
+ κiψ
k+1nk+1i = 0, 1 ≤ i ≤ I,
where {0 . . . I} is the set of all values of i to be considered in the discretization. Taking
∆t = ∆x (CFL = 1), we obtain the following compact discretization scheme:

nk+1i =
nki−1
1+∆tκiψk+1
, 1 ≤ i ≤ I,
nk+10 = 2ψ
k
∑
0≤i≤I
κin
k
i∆t.
(2)
Assume ψ is periodic of period T ≥ 0 and consider a grid over [0, T ]× [0, I∆t], consisting
of squares with sides of length ∆t = T/NT , for some NT ∈ N (and I large enough, partic-
ularly I∆t > a and I + 1 > NT ). Then, the populations at time (k + 1)∆t for all ages in
[0, I∆t] can be obtained from the corresponding populations at time k∆t as follows:

nk+10
nk+11
.
.
.
nk+1I

 =


2ψkκ0∆t . . . 2ψkκI−1∆t 2ψ
kκ
I
∆t
1
1+∆tψk+1κ1
. . . 0 0
.
.
.
.
.
.
.
.
.
.
.
.
0 . . . 1
1+∆tψk+1κ
I
0




nk0
nk1
.
.
.
nkI

 (3)
It is clear that the matrix in (3) depends only on the time index k and is periodic of period
NT . We denote Mk this matrix and the vectors respectively nk and nk+1. The equation (3)
can be written nk+1 =Mknk.
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5.2 Approximating the eigenvalue
The algorithm has already been discussed in [25]. We recall that the growth rate is defined as
the unique real λF such that (1) admits solutions of the form N(t, x)eλF t with N > 0 and
N(., x) is periodic. We can approximate it thanks to:
Lemma 6 (Discrete Floquet theorem).
There exists a unique real λ and a unique sequence of vectors (N k)k∈N ,N k =
(
N ki
)
0≤i≤I
such that
N ki > 0,
I∑
i=0
N 0i = 1, (4)
k 7→ (N k) is NT -periodic, (5)
nk, defined by nk = N keλ.k∆t is solution to (3) (6)
Proof. The proof is standard and we recall it for the sake of completeness. It is based on the
Perron Frobenius theorem. First we prove uniqueness. Supposing there exists such nk, we
have
n1 = M0n
0,
n2 = M1n
1 =M1M0n
0,
. . . (7)
nk+1 = Mkn
k =MkMk−1 . . .M1M0n
0, (8)
. . .
nNT = MNT−1MNT−2 · · ·M1M0n
0. (9)
We define
M =MNT−1MNT−2 · · ·M1M0,
thus, (9) reads nNT = Mn0.
Lemma 7. The matrix M is nonnegative and primitive (and therefore is irreducible).
Proof. The nonnegativity is obvious. To prove the primitivity, the key point is I+1 > NT and
I∆t ≥ a+2∆t. For some ε > 0 we have for any k, if we denote by Idk the identity matrix of
order k,
Mk ≥ ε
(
0 . . . 0 1 1
IdI 0
)
= εW.
Notice that W is the Wielandt matrix of order I +1 which is known to be primitive (see [15]).
Therefore for some p, W p > 0 and thus for qNT ≥ p,
M
q ≥ εqNTW qNT > 0,
which yields the primitivity of M, the spectral radius of which, denoted here by ρ is then posi-
tive. We denote by ρ its spectral radius. We have ρ > 0.
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Back to the proof of the discrete Floquet theorem, we have
nNT = eλNT∆tNNT = eλTN 0 = eλTn0.
Hence we have Mn0 = eλTn0. This means that n0 is a positive eigenvector of M associated
to a positive eigenvalue eλT . From the Perron-Frobenius theorem, eλT = ρ and n0 = N 0 is
the (unique) associated eigenvector. The solution is unique.
Conversely, if we know the Perron eigenvector V and the Perron eigenvalue ρ of M, then the
sequence
(
N k
)k∈N
defined by
{
N 0 = V,
N k+1 = e−λ∆t.MkN
k,
satisfies (4),(5) and (6) for λ = log(ρ(M)).
For multiphase models, the idea is mainly the same. To compute ρ = eλT the spectral
radius of M, the power algorithm is used. It converges thanks to the primitivity of M.
5.3 Numerical results
First we present some numerical results to illustrate theorem 2. We scale T = 1. We fix the
value of K0 to 2 and test various periodic function ψ. We plot the curves
a → λF (a, ψ),
a → λP (a)
We recall that the eigenvalues for the Perron problem can be directly computed thanks to
lemma 3. From theorem 2, we know that these curves cross for x-coordinate a = T , the second
part of the theorem tells us that we expect (locally) the curve for λF to be above the curve for
λP for a < T and below it for a > T . We plot the curves λ = λP (a) and λ = λF (a, ψ) for
our functions ψ and look at the crossing of curves around T (on the simulations, T = 1). We
also give a more global view of λF (a, ψsin) and λP in figure 3 to illustrate the fact that the
comparison is only local. Here, the parameters h and δ are respectively set to 3 and 0.3.
Name of the function Formulation on the interval [0, 1[ 〈ψ2〉
ψsq (square wave) 1.8χ[0,1/2[(t) + 0.1χ[1/2,1[ 1.81
ψpk (peak function) 0.1 + ht/δχ[0,δ[(t) + (2h− ht/δ)χ[δ,2δ[(t) 1.99
ψsin (sinusoidal) 1 + 0.9 cos(2pit) 1.405
Table 1: Functions ψ for the simulations
From the last part of the demonstration of theorem 2, we expect,
∂λF (a, ψpk)
∂a |a=T
>
∂λF (a, ψsq)
∂a |a=T
>
∂λF (a, ψsin)
∂a |a=T
,
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Figure 2: Crossing of the Perron and Floquet curves (detail) for ψ = ψsin.
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Figure 3: Crossing of the Perron and Floquet curves for ψ = ψsin.
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Figure 4: Crossing of the Perron and Floquet curves for ψ = ψsin (dash dot), ψsq (dots) and ψpk
(long dash).
we give figure 4 as a confirmation. Finally we give some simulations to illustrate our remarks
on chronotherapy.
For the chronotherapy simulation we use the following parameter: we fix I = 3 (we
consider S and G2 as a single phase). The parameter γ is a periodic function (with strong
variations on a period to have a stronger effect of the parameter θ ∈ (0, 1)). We compute the
eigenvalue for a death rate in phase 2 (phase S-G2) having the value εγ(t+ θ). We test several
value of ε to determine whether or not the amplitude of the death rate changes the relative
behavior of the eigenvalue with respect to θ.The coefficients have the form:
Ki→i+1(t, x) = Kiψi(t)χ[ai,∞[(x),
whereKi, ai are positive, ψi is a positive 1 periodic function. We give a simulation for the case
described in the appendix (a case for which we can compute explicitly ∫∞0 N2φ2(t, x)dx). We
fix Ki = 10 for all i, a1 = 10/24, a2 = 12/24 = 0.5, a3 = 2/24, ψ(t) = 1 + 0.9 cos(2pit)
and ψi defined from ψ as in the appendix. We choose γ(t) = cos6(2pit). With these choices
of coefficients, we compute∫ ∞
0
N2φ2(t, x)dx = C −C
′ sin(2pit),
where C and C ′ are positive constants. Therefore,
lim
ε→0
λε,θ − λ0
ε
= C + C ′ sin(2piθ).
In figure 5, we remark especially that the location of the optimal phase does not depend on
ε (since we have θoptimal = 14 whatever the value of ε) and corresponds exactly to the value of
θ maximizing sin(2piθ), i.e., minimizing
∫ 1
0 γ(t+ θ)
∫∞
0 N2φ2dxdt.
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Figure 5: Variation of the Floquet eigenvalue with respect to the parameter θ for various amplitude
for fixed γ and amplitude ε = 0.1, 0.5, 1 (from left to right).
Concluding remarks
The results of the present paper show that the periodic control on the transition rate Ki→i+1 of
cell cycle models yields richer behaviors than in the case in which only the death rates di are
subject to a periodic control [8, 9]. In particular, the inequality of [8, 9] does not carry over.
This is, to our knowledge, the first time that such results are shown -on special cases of the
control- analytically, thus confirming numerical results first shown in [8, 9].
Our results also indicate that multiphase cell proliferation models are the simplest candi-
dates to represent the effects of chronotherapy. Indeed, as shown in section 4.1, in single-phase
models, in the simple case when only death rates di are controlled by a periodic forcing term,
the growth rate λ is modified by a term depending only on the average over a period of the
forcing term, so that no phase of the periodic control function can be relevant to account for
differences in the resulting growth rate, contrary to what is observed in chronotherapy [18].
Furthermore such multiphase models take into account the existence of multiple checkpoints ,
and we know from cell cycle physiology that the minimal number of checkpoints to consider
is 2: at G1/S and G2/M.
We performed numerical and graphical results of section 5, on a 3-phase model with 1-
periodic control on all phase transition functions Ki→i+1, where one represents chronotherapy
as a 1-periodic death term εγ of amplitude ε acting on the second phase (S/G2) only. These
preliminary computational results, in particular performed in a simple analytically tractable
case, seem to indicate that the effect of a chronotherapy on the growth rate λ(ε, θ) highly
depends on the amplitude ε of the death rate but that the optimal phase θ (related to the best
peak infusion phase) is independent on ε (see figure 5). In future work, we intend to introduce
also an effect of chronotherapy on the transition rates Ki→i+1.
From a more general point of view (i.e., independently of chronotherapeutic considera-
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tions), Theorem 2 analytically shows, at least in the single-phase case, that under the control
of a periodic function exerting its influence on cell division, a selective advantage is given
to those cells that are able to divide with a cell cycle duration slightly lower than the control
function period. But, as numerically illustrated on Fig. 3, this cell cycle duration should be not
too much lower than the control period, or else the advantage is lost. This leads to a biological
speculation (or prediction): in a population of proliferating cells with variable cycle duration
times, all being under the control of a common 24 h-periodic circadian clock, those cells that
are well controlled by the clock, and endowed with a cycle duration between say 21 h and 23 h
should quickly outnumber the others. Hence in proliferating healthy tissues (fast renewing tis-
sues such as gut or bone marrow), an intrinsic cell cycle time of 21 to 23 h should be observed
(if such an observation is possible).
Now to explain the initial tumour growth data that first motivated this study, we can spec-
ulate in the following way: tumour cells are less sensitive than healthy cells to circadian clock
control (indeed it is known from chronotherapeutics in oncology that “in contrast with consis-
tent rhythmic changes in drug tolerability mechanisms in host tissues, tumour rhythms appear
heterogeneous with regard to clock gene expression and rhythm in pharmacology determi-
nants as a function of tumour type and stage”[18]), so that their proliferation is more likely to
be governed by a simple Perron eigenvalue rather than by one of the Floquet type. Tumour
surrounding healthy cells and host immune cells, in contrast with tumour cells, are still un-
der circadian control and they may thus have a selective advantage over cancer cells as long
as this circadian control is present. Circadian clock disruption by perturbed light-dark cycle
destroys this advantage, and these perturbed host cells oppose in a less efficient way local tis-
sue invasion by cancer cells, hence the resulting curves shown in the introduction. Of course
such speculation remains to be documented (in particular by investigating differential circadian
clock control on proliferation in tumour and healthy tissues), but this is our best explanation
so far for this phenomenon.
A Appendix
A.1 Existence theory for λ
This part is dedicated to the demonstration of the existence of the Floquet eigenvalue. Partic-
ularly, we try to prove it under general hypothesis on the periodic function ψ. For instance, a
short adaptation of the demonstration given in [20] would be sufficient for the case of a pos-
itive continuous periodic function ψ, but one would like to have the possibility of studying
non smooth functions such as a square wave (which for instance could have value 1 during the
day and 0 during the night). We give a proof of the existence of the Floquet eigenvalue in the
one-phase model. It can easily be adapted for a multiphase-model with out death rates where
the coefficients would have the form Ki→i+1 = Kiψi(t)χ[ai,+∞[ with the same hypothesis
on the functions ψi. We prove here existence of a solution to three eigenproblems: the direct
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eigenproblem

∂tN(t, x) + ∂xN(t, x) + (λ+Kψ(t)χ[a,+∞[(x))N(t, x) = 0,
N(t, 0) = 2Kψ(t)
∫∞
a N(t, x)dx,
N ≥ 0,
∫∞
0 Ndx = 1,
(10)
the dual eigenproblem{
−∂tφ(t, x) − ∂xφ(t, x) + (λ+Kψ(t)χ[a,+∞[(x))φ(t, x) = 2Kψ(t)χ[a,∞[(x)φ(t, 0),
φ > 0,
∫∞
0 Nφdx = 1, (11)
and the delay differential equation
P˙ (t) = −(Kψ(t) + λ)P (t) + 2Ke−λaψ(t− a)P (t− a), P > 0,
∫ 1
0
P (t)dt = 1. (12)
We give a normalization for P to ensure uniqueness.
Theorem 8. For any positive T -periodic bounded function ψ 6= 0, a ≥ 0 here exists a unique
λ,N, φ, P such that P > 0 is solution to (5) and N ≥ 0 is solution to (2) (N > 0 if ψ is
positive).
The proof is based on the Krein-Rutman theorem (see [10] for instance). We consider a
T -periodic nonnegative bounded function ψ 6= 0. We adapt the proof from [20] to our case.
First, using the methods of characteristics for the partial differential equations, we reduce the
eigenproblems to integral equations on N(t, 0), φ(t, 0) and P . We consider three operators
depending on a parameter µ. For a bounded T -periodic function M, we define Ni = Li(M)
by
N1(t) = 2K
∫ ∞
a
ψ(t− x)e−µx−K
R x
a
ψ(t−x+s)dsM(t− x)dx, (13)
N2(t) = 2K
∫ ∞
a
ψ(t)e−µx−K
R x
a
ψ(t−x+s)dsM(t− x)dx, (14)
N3(t) = 2K
∫ ∞
a
ψ(t+ x)e−µx−K
R x
a
ψ(t+s)dsM(t+ x)dx. (15)
These operators are defined such that for µ = λ, we get,
P (t) = L1(P )(t),
N(t, 0) = L2(N(., 0))(t),
φ(t, 0) = L3(φ(., 0))(t).
This means that the functions should be nonnegative eigenvectors of these three operators
associated to the eigenvalue 1.
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Lemma 9. For µ ≥ 0,
• Li maps L∞per(0, T ) into itself,
• L1,L3 are continuous compact operators on Cper(0, T ),
• L1,L3 are strongly positive and L2 is nonnegative (strongly positive if ψ > 0).
Proof. For M bounded, one has, since for x > a,
∫ x
a ψ(t)dt ≤ 〈ψ〉(x− a) + ‖ψ‖∞T ,
‖Li(M)‖∞ ≤ 2
‖ψ‖∞
〈(ψ)〉
eK‖ψ‖∞T ‖M‖∞ = C‖M‖∞.
For continuity and compactness we only explicit the proof for i = 1, the case i = 3 is very
similar. We consider M continuous and h small,
N1(t+ h) = 2K
∫ ∞
a
ψ(t+ h− x)e−µx−K
R x
a
ψ(t+h−x+s)dsM(t+ h− x)dx,
= 2K
∫ ∞
a−h
ψ(t− x)e−µ(x+h)−K
R x+h
a
ψ(t−x+s)dsM(t− x)dx,
= 2K
∫ a
a−h
ψ(t− x)e−µ(x+h)−K
R x+h
a
ψ(t−x+s)dsM(t− x)dx
+ 2K
∫ ∞
a
ψ(t− x)e−µ(x+h)−K
R x+h
a
ψ(t−x+s)dsM(t− x)dx,
= Ah + 2K
∫ ∞
a
ψ(t− x)
(
e−µ(x+h)−K
R x+h
a
ψ(t−x+s)ds − e−µx−K
R x
a
ψ(t−x+s)ds
)
M(t− x)dx
+ 2K
∫ ∞
a
ψ(t− x)e−µx−K
R x
a
ψ(t−x+s)dsM(t− x)dx,
= Ah +Bh +N1(t).
We have bounds on Ah and Bh,
|Ah| ≤ 2K‖ψ‖‖M‖∞h,
|Bh| ≤ K‖ψ‖∞h‖N1‖∞ ≤ CK‖ψ‖∞‖M‖∞h.
Therefore, using (A.1),(A.1), we obtain the continuity and the compactness of operator L1.
Using the same techniques we can prove continuity and compactness of operator L3. The
operator L2 needs regularity on ψ to be compact (and continuous). All these operators are
positive. We can apply the Krein-Rutman theorem (weak form [10]). We denote ρ1, ρ3 the
spectral radii of respectively L1,L3. They are positive (since L(1) ≥ ε > 0, ρ1 ≥ ε), so are
the associated nonnegative eigenfunctions. If M1(t) = 0, then
ψ(t− x)M1(t− x) = 0, for x ≥ a,
which leads to ψM1 ≡ 0 and ρ1M1 ≡ 0.Therefore M1 and similarly M3 can not vanish.
Lemma 10.
L2(ψM1) = ρ1ψM1,
ρ1 = ρ3.
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Proof. The first point is a straightforward computation. The second point uses the duality of
operators L2 and L3,∫ T
0
L2(ψM1)(t),M3(t)dt =
∫ T
0
ψ(t)M1(t)L3(M3)(t)dt,
ρ1
∫ T
0
ψ(t)M1(t)M3(t)dt = ρ3
∫ T
0
ψ(t)M1(t)M3(t)dt.
The existence of a solution to (5) is equivalent to the existence of a positive fixed point of L1
for µ = λ, therefore, we need to find µ such that ρ1(µ) = 1. For µ = 0, we have
L3(1) = 2.
Therefore ρ1(0) = 2. As ρ is a decreasing function of µ and ρ1(∞) = 0, there exists some
positive λ such that ρ1(λ) = 1. The solution to (5) is then given by such λ and P = M1.
Then, the function N defined N(t, 0) = ψ(t)M1(t) and the characteristics
N(t, x) = N(t− x, 0)e−λx−
R x
0
Kψ(t−x+s)χ[a,∞[(s)ds,
is solution to (2). We remark then, as λ > 0, that N(t,∞) = 0. Similarly, we define φ by
φ(t, x) =
∫ ∞
x
Kψ(t+ y − x)χ[a,∞[(y)φ(t+ y − x, 0)e
−
R y
x
λ+Kψ(t+s−x)χ[a,∞[(s)dsdy.
This is a solution to (11).
A.2 Explicit solutions for the multiphase eigenproblem
In the following T = 1.
We give here explicit solutions to the eigenproblem in the multiple phases case. We do not
give details for the demonstration. We consider a 3 phase model without death terms, where
the transition terms have the form:
Ki→i+1(t, x) = Kiψi(t)χ[ai,∞[(x).
Here, ψi is a positive 1-periodic function satisfying 〈ψi〉 = 1. We consider the following very
specific case: we choose a1, a2, a3 > 0 such that a1 + a2 + a3 = 1, and we choose ψi in the
following way, for a fixed positive 1-periodic function ψ,
ψ1(t) = ψ(t),
ψ2(t) = ψ(t− a2),
ψ3(t) = ψ(t− a2 − a3).
To explain the form of the coefficients, we make the following remark: if we denote Pi(t) =∫∞
ai
Ni(t, x)dx (the same idea as for the one phase model), the 1-periodic functions Pi satisfies
a system of delay differential equations and since a1 + a2 + a3 = 1, the 1-periodic functions
21
Qi defined by Q1(t) = P1(t), Q2(t) = P2(t+ a2), Q3(t) = P3(t+ a2 + a3) satisfy a system
of ordinary differential equations.
d
dt

 Q1(t)Q2(t)
Q3(t)

 = −

 −λ−K1ψ(t) 0 2K3e−λa1ψ(t)K1e−λa2ψ(t) −K2ψ(t) − λ 0
0 K2e
−λa3ψ(t) −K3ψ(t) − λ



 Q1(t)Q2(t)
Q3(t)

 .
We denote M(t) the above matrix. Due to the special form of the functions ψi, we have
M(t)M(t′) =M(t′)M(t), for all t, t′. Therefore we can write
Q(t) = exp
(∫ t
0
M(s)ds
)
Q(0).
The vector Q(t) is 1-periodic, thus, Q(0) has to be a positive eigenvector of exp(
∫ 1
0 M(s)ds)
associated to the eigenvalue 1. The matrix exp(
∫ 1
0 M(s)ds) has eigenvalue 1 if and only if
(K1 + λ)(K2 + λ)(K3 + λ)− 2K1K2K3e
−λ(a1+a2+a3) = 0. (16)
This leads toQi(t) = eλ
R t
0 (ψ(s)−1)dsQi(0), whereQ(0) is a positive vector satisfying
∫ 1
0 M(s)dsQ(0) =
0. Then, we can compute Pi(t) and Ni(t, 0). Finally, using the methods of characteristics, the
eigenfunctions Ni are given, up to a normalization, by
N1(t, x) = 2K3U3ψ(t+ a1 − x)e
λ
R t−x+a1
0 (ψ(s)−1)ds−λx−
R x
0 K1ψ(t−x+s)χ[a1,∞[(s)ds,
N2(t, x) = K1U1ψ(t− x)e
λ
R t−x
0 (ψ(s)−1)ds−λx−
R x
0 K2ψ(t−x+s−a2)χ[a2,∞[(s)ds,
N3(t, x) = K2U2ψ(t− a2 − x)e
λ
R t−x−a2
0 (ψ(s)−1)ds−λx−
R x
0
K3ψ(t−x+s−a2−a3)χ[a3,∞[(s)ds,
where 
 U1U2
U3

 =


1
K1e−λa2
K2+λ
K1+λ
2K3e−λa1

 .
The adjoint eigenfunctions are given by the formulas
φ1(t, x) = e
−λ
R t−a2−a3−min(x,a1)
0 (ψ(s)−1)ds+λmin(x,a1)V1,
φ2(t, x) = e
−λ
R t−min(x,a2)
0 (ψ(s)−1)ds+λmin(x,a2)V2,
φ3(t, x) = e
−λ
R t−a2−min(x,a3)
0 (ψ(s)−1)ds+λmin(x,a3)V3,
where 
 V1V2
V3

 =


1
K1+λ
K1e−λa1
2K3e−λa3
K3+λ

 .
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Basically, the ideas for the computations of φi are the same, based on the following remark, as
φi(t, x) =
∫ ∞
0
Ki→i+1(t+ y, x+ y)φi+1(t+ y, 0)e
−
R y
0
λ+Ki→i+1(t+y′,x+y′)dy′dy,
(with a factor 2 for i = 3), we have φi(t, x) = φ(t, ai) for a ≥ ai. This leads to a
differential equation for φi(t, 0). Details are left to the reader. In this case, we compute∫∞
0 Ni(t, x)φi(t, x)dx. As we have φi(t, x) = φi(t, ai) for x ≥ ai,∫ ∞
0
Ni(t, x)φi(t, x)dx =
∫ ai
0
Ni(t, x)φi(t, x)dx+ φi(t, ai)
∫ ∞
ai
Ni(t, x)dx.
We have ∫ ∞
0
N1(t, x)φ1(t, x) = (K1 + λ)e
λa1
∫ a1
0
ψ(t− x+ a1)dx+ U1V1e
λa1 ,
∫ ∞
0
N2(t, x)φ2(t, x)dx = (K1 + λ)e
λa1
∫ a2
0
ψ(t− x)dx+ U2V2e
λa2 ,
∫ ∞
0
N3(t, x)φ3(t, x)dx = (K1 + λ)e
λa1
∫ a3
0
ψ(t− a2 − x)dx+ U3V3e
λa3 .
Particularly, in this case,
∫∞
0 Niφdx is not always constant. We denote Ψ(t) =
∫ t
0 (ψ(s)−1)ds,
it is a 1 periodic function. We also denote Ci = UiVieλai , C = (K1 + λ)eλa1 , both these
constants are positive,∫ ∞
0
N1(t, x)φ1(t, x) = C(a1 +Ψ(t)−Ψ(t+ a1)) + C1,
∫ ∞
0
N2(t, x)φ2(t, x)dx = C(a2 +Ψ(t− a2)−Ψ(t)) + C2,
∫ ∞
0
N3(t, x)φ3(t, x)dx = C(a3 +Ψ(t+ a1)−Ψ(t− a2)) + C3.
For instance, using the parameters of the simulation, we have, Ψ(t) = 0.92pi sin(2pit), a2 = 0.5,∫ ∞
0
N2φ2(t, x)dx = (Ca2 + C2)− 2C
0.9
2pi
sin(2pit) = C ′ − C ′2 sin(2pit),
∫ 1
0
γ(t+θ)
∫ ∞
0
N2φ2(t, x)dx = C
′
∫ 1
0
cos6(2pi(t+θ))dt−C ′2
∫ 1
0
cos6(2pi(t+θ)) sin(2pit)dt,
a short computation leads to
γ(t) =
1
32
cos(6pit) +
3
24
cos(4pit) +
15
32
cos(2pit) +
5
16
,
therefore, ∫ 1
0
γ(t+ θ)
∫ ∞
0
N2φ2(t, x)dx = C
′′ − C ′′2 sin(2piθ),
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Where C ′′ ≥ C ′′2 > 0. Therefore, in this particular case,
lim
λε,θ − λ0
ε
= C ′′2 sin(2piθ)− C
′′.
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